• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Adding USP14 Expression Improves Deep Infiltrating Endometriosis Recurrence Prediction Models

by
November 18, 2026
in Health
Reading Time: 3 mins read
0
Adding USP14 Expression Improves Deep Infiltrating Endometriosis Recurrence Prediction Models

Adding USP14 Expression Improves Deep Infiltrating Endometriosis Recurrence Prediction Models

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In a retrospective cohort study of patients undergoing surgical treatment for deep infiltrating endometriosis, researchers established that elevated ubiquitin-specific protease 14 mRNA expression in lesions is independently associated with postoperative symptomatic recurrence. Integrating this molecular biomarker with standard clinical factors produced a combined clinico-molecular predictive model that demonstrated superior prognostic accuracy compared to a model relying solely on clinical features. This approach provides measurable prognostic improvements for identifying patients facing higher likelihoods of postoperative symptom return.

Deep infiltrating endometriosis frequently exhibits high postoperative recurrence rates, presenting a persistent clinical challenge following surgical intervention. Although current risk models are used to anticipate patient trajectories, existing frameworks lack molecular insights required for precise individualized risk stratification. To address this diagnostic gap, investigators examined whether ubiquitin-specific protease 14, or USP14, mRNA expression in surgically resected lesions is independently associated with postoperative symptomatic recurrence and whether combining this biomarker with clinical variables could enhance overall predictive accuracy.

The research team evaluated a retrospective cohort of 235 surgically treated patients diagnosed with deep infiltrating endometriosis. To isolate the most informative predictor variables from the clinical and molecular data, investigators applied the least absolute shrinkage and selection operator, widely known as LASSO. Following this variable selection procedure, Cox multivariate regression analysis was conducted to establish independent risk factors and protective determinants associated with time to postoperative symptomatic recurrence across the cohort.

Multivariate Cox regression demonstrated that high USP14 expression was an independent risk factor for symptomatic recurrence, yielding a hazard ratio of 1.656 with a 95 percent confidence interval of 1.307 to 2.099 and a p-value of less than 0.001. Anatomical and clinical characteristics also emerged as independent risk factors: pelvic adhesions yielded a hazard ratio of 1.861 (95% CI: 1.013–3.419; P = 0.045), bowel lesions showed a hazard ratio of 2.168 (95% CI: 1.278–3.679; P = 0.004), and coexisting adenomyosis conferred a hazard ratio of 2.645 (95% CI: 1.568–4.462; P < 0.001).

The multivariate Cox regression simultaneously identified two independent protective factors associated with significantly lower rates of postoperative recurrence. Patients who received gonadotropin-releasing hormone agonist therapy for at least six months demonstrated a markedly reduced recurrence risk, recording a hazard ratio of 0.126 with a 95 percent confidence interval of 0.044 to 0.363 and a p-value under 0.001. In addition, achieving postoperative pregnancy served as an independent protective factor, associated with a hazard ratio of 0.402 (95% CI: 0.200–0.807; P = 0.010).

When investigators integrated USP14 expression with these identified clinical determinants, the combined model achieved a concordance index, or C-index, of 0.896 with a 95 percent confidence interval of 0.879 to 0.912. This performance outperformed the clinical-only predictive model, which achieved a C-index of 0.870 with a 95 percent confidence interval of 0.849 to 0.892. To assess model optimism, the researchers conducted internal bootstrap validation with 2,000 resamples, yielding optimism-corrected C-indices of 0.888 for the combined model and 0.863 for the clinical-only model.

Evaluation of discrimination and reclassification supported the incremental predictive utility of incorporating USP14. The integrated discrimination improvement was 0.044 (95% CI: -0.013 to 0.11; P = 0.047); because the bootstrap confidence interval narrowly included zero, investigators interpreted this finding as borderline. However, complementary evaluation metrics affirmed the biomarker’s value, showing a continuous net reclassification improvement of 0.655 (P = 0.026) and a bootstrap-validated difference in C-index of 0.020 (95% CI: 0.002–0.048; P = 0.033).

The study concluded that high USP14 expression in lesions independently correlates with postoperative symptomatic recurrence, and its addition to clinical variables provides modest but consistent prognostic improvement. Nonetheless, because this clinico-molecular model was developed retrospectively and evaluated solely through internal validation, the investigators emphasized that it remains hypothesis-generating, concluding that rigorous external, multi-center validation is required before any potential clinical implementation.

Subject of Research: Prediction of postoperative symptomatic recurrence in deep infiltrating endometriosis using lesion USP14 gene expression and clinical factors

Article Title: USP14 Gene Expression Combined with Clinical Factors for Predicting Symptomatic Recurrence After Surgery for Deep Infiltrating Endometriosis: A Retrospective Cohort Study

Article References: Zhang, P., & Xiao, X. (2026). USP14 Gene Expression Combined with Clinical Factors for Predicting Symptomatic Recurrence After Surgery for Deep Infiltrating Endometriosis: A Retrospective Cohort Study. Reproductive Sciences. https://doi.org/10.1007/s43032-026-02259-5

Image Credits: AI Generated

DOI: 10.1007/s43032-026-02259-5

Keywords: deep infiltrating endometriosis, USP14, ubiquitin-specific protease 14, symptomatic recurrence, postoperative recurrence, retrospective cohort study, LASSO regression, Cox multivariate regression, pelvic adhesion, bowel lesions, adenomyosis, GnRH-a therapy, postoperative pregnancy, C-index, bootstrap internal validation, integrated discrimination improvement, net reclassification improvement, prognostic models

News Source: Ophelia Keating. (November 18, 2026). Adding USP14 Expression Improves Deep Infiltrating Endometriosis Recurrence Prediction Models. Scienmag.

Tags: Adenomyosisbootstrap internal validationbowel lesionsC-indexCox multivariate regressiondeep infiltrating endometriosisGnRH-a therapyintegrated discrimination improvementLASSO regressionnet reclassification improvementpelvic adhesionpostoperative pregnancypostoperative recurrenceprognostic modelsretrospective cohort studysymptomatic recurrenceubiquitin-specific protease 14USP14
Share12Tweet7Share2ShareShareShare1

Related Posts

Late Alteplase Linked to Better Discharge Stroke Recovery but Higher Hemorrhage Risk

Late Alteplase Linked to Better Discharge Stroke Recovery but Higher Hemorrhage Risk

November 18, 2026
Trochlear Dysplasia and Anatomical Risk Factors Clarify Distinct Patellar Instability Patterns

Trochlear Dysplasia and Anatomical Risk Factors Clarify Distinct Patellar Instability Patterns

November 18, 2026

Pesticide Handlers in Tanzanian Agriculture Show Significant Acetylcholinesterase Enzyme Suppression

November 18, 2026

Rare Unilateral Neuroretinitis Linked to Dengue Infection in Returning Traveller

November 18, 2026

POPULAR NEWS

  • Electroacupuncture Mobilizes Unique CD34-Positive Stem-Like Cells in Healthy Dogs

    Electroacupuncture Mobilizes Unique CD34-Positive Stem-Like Cells in Healthy Dogs

    29 shares
    Share 12 Tweet 7
  • Specialists Outline Cervical Cancer Screening Principles for Resource-Limited Settings

    29 shares
    Share 12 Tweet 7
  • Modified Halpern Proximal Algorithm Solves Multi-Structured Problems in Curved Hadamard Spaces

    29 shares
    Share 12 Tweet 7
  • Machine Learning Outperforms Pharmacokinetic Models Predicting Initial Vancomycin Concentrations in Septic Patients

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Late Alteplase Linked to Better Discharge Stroke Recovery but Higher Hemorrhage Risk

Screening Strategy Uncovers MAP3K1 Degrader With Potent Preclinical Anticancer Activity

Trochlear Dysplasia and Anatomical Risk Factors Clarify Distinct Patellar Instability Patterns

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.